INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES

$447,239P01FY2007CANIH

Ohio State University, Columbus OH

Investigators

John C Byrdcontact

Linked publications & trials

Paper 39330666 Paper 38797949 Paper 34027313 Paper 33441177 Paper 32804708 Paper 32429929 Paper 31338557 Paper 31151986 Paper 31138333 Paper 31116161 Paper 30962859 Paper 30910862 Paper 30833178 Paper 30737226 Paper 30287389 Paper 30193847 Paper 30183689 Paper 30132912 Paper 30030269 Paper 30020196 Paper 29868798 Paper 29769244 Paper 29735668 Paper 29560128 Paper 29483911 Paper 29363526 Paper 29296799 Paper 29229679 Paper 29166586 Paper 29133913 Paper 28842466 Paper 28827320 Paper 28724544 Paper 28723548 Paper 28714866 Paper 28688082 Paper 28515090 Paper 28496177 Paper 28479263 Paper 27993723 Paper 27917390 Paper 27783987 Paper 27780867 Paper 27775550 Paper 27757311 Paper 27729802 Paper 27664883 Paper 27581603 Paper 27458141 Paper 27435400 Paper 27387131 Paper 27373165 Paper 27287425 Paper 27226587 Paper 27178467 Paper 27136276 Paper 27035691 Paper 27013443 Paper 26947772 Paper 26880800 Paper 26865456 Paper 26813675 Paper 26766586 Paper 26694610 Paper 26641137 Paper 26627823 Paper 26472752 Paper 26470881 Paper 26442611 Paper 26238487 Paper 26232774 Paper 26223896 Paper 26182309 Paper 26158860 Paper 26155832 Paper 25999435 Paper 25979947 Paper 25972157 Paper 25852576 Paper 25804339 Paper 25800048 Paper 25787252 Paper 25769609 Paper 25708835 Paper 25700432 Paper 25667415 Paper 25595786 Paper 25593320 Paper 25587717 Paper 25486872 Paper 25305035 Paper 25301708 Paper 25293770 Paper 25271622 Paper 25258342 Paper 25082342 Paper 25079333 Paper 25048786 Paper 24953655 Paper 24947019

View original record on NIH RePORTER →